Compare EVO & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | KRUS |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.6M | 459.1M |
| IPO Year | 2007 | 2019 |
| Metric | EVO | KRUS |
|---|---|---|
| Price | $1.59 | $25.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $4.48 | ★ $46.63 |
| AVG Volume (30 Days) | 65.9K | ★ 294.6K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $328,276,000.00 |
| Revenue This Year | N/A | $15.24 |
| Revenue Next Year | $18.90 | $17.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.10 |
| 52 Week Low | $1.33 | $24.98 |
| 52 Week High | $3.87 | $80.84 |
| Indicator | EVO | KRUS |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 32.02 |
| Support Level | $1.50 | N/A |
| Resistance Level | $1.61 | $59.30 |
| Average True Range (ATR) | 0.06 | 2.15 |
| MACD | 0.01 | -0.73 |
| Stochastic Oscillator | 28.13 | 7.51 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.